NOVOSTEO

novosteo-logo

Novosteo, Inc. is a startup developing and delivering new drugs for the treatment of bone injury and diseases that impact patients' morbidity, mortality and loss of mobility and productivity associated with bone fractures, bone metastasis and infection. Scientific co-founders Stewart Low and Philip Low of Purdue University have created a proprietary chemistry approach to bone targeting and have discovered novel biologics that accelerate bone regeneration by delivering anabolic agents preferentially to fracture surfaces.

#SimilarOrganizations #People #Financial #Website #More

NOVOSTEO

Social Links:

Industry:
Biotechnology Health Care Pharmaceutical

Founded:
2017-01-01

Address:
Indiana, Pennsylvania, United States

Country:
United States

Website Url:
http://www.novosteo.com

Total Employee:
1+

Status:
Active

Contact:
765-761-3912

Total Funding:
7.95 M USD

Technology used in webpage:
SPF Microsoft Exchange Online Amazon Office 365 Mail Amazon Route 53 Amazon S3 CDN Lorem Ipsum


Similar Organizations

1200-pharma-logo

1200 Pharma

1200 Pharma is a medicinal chemistry technology company that accelerates pre-clinical drug discovery and clinical approval timelines.

apic-bio-logo

Apic Bio

Apic Bio is a gene therapy company that develops treatment options for rare, undertreated neurological and liver diseases.

braeburn-logo

Braeburn

Braeburn is dedicated to delivering solutions for people living with the serious consequences of opioid use disorder.

forma-therapeutics-logo

FORMA Therapeutics

FORMA Therapeutics is a biopharmaceutical company focused on the discovery, development, and commercialization of transformative medicines.

eden-biologics-logo

Eden Biologics

Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.

nuchem-sciences-logo

NuChem Sciences

NuChem Sciences is a drug discovery in chemistry contract research organization (CRO) located in Montréal and Lévis.

tiburio-therapeutics-logo

Tiburio Therapeutics

Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.


Current Advisors List

isaac-barchas_image

Isaac Barchas Board Member @ Novosteo
Board_member
2019-02-01

Current Employees Featured

dan-hasler_image

Dan Hasler
Dan Hasler CEO @ Novosteo
CEO

philip-low_image

Philip Low
Philip Low Co-founder & Director @ Novosteo
Co-founder & Director
2017-05-01

stewart-low_image

Stewart Low
Stewart Low VP of Research and Development and Co-Founder @ Novosteo
VP of Research and Development and Co-Founder
2017-03-01

brendan-hannah_image

Brendan Hannah
Brendan Hannah Chief Operating Officer @ Novosteo
Chief Operating Officer
2021-11-01

scott-salka_image

Scott Salka
Scott Salka Executive Chairman @ Novosteo
Executive Chairman
2019-08-01

Founder


philip-low_image

Philip Low

stewart-low_image

Stewart Low

Investors List

kairos-venture-investments-llc_image

Kairos Ventures

Kairos Ventures investment in Series A - Novosteo

biocrossroads_image

BioCrossroads

BioCrossroads investment in Series A - Novosteo

purdue-research-foundation_image

Purdue Research Foundation

Purdue Research Foundation investment in Series A - Novosteo

elevate-ventures_image

Elevate Ventures

Elevate Ventures investment in Series A - Novosteo

research-bridge-partners_image

Research Bridge Partners

Research Bridge Partners investment in Seed Round - Novosteo

purdue-research-foundation_image

Purdue Research Foundation

Purdue Research Foundation investment in Pre Seed Round - Novosteo

national-institutes-of-health_image

National Institutes of Health

National Institutes of Health investment in Grant - Novosteo

Official Site Inspections

http://www.novosteo.com

  • Host name: s3-website-us-east-1.amazonaws.com
  • IP address: 52.216.208.93
  • Location: Ashburn United States
  • Latitude: 39.0481
  • Longitude: -77.4728
  • Metro Code: 511
  • Timezone: America/New_York
  • Postal: 20149

Loading ...

More informations about "Novosteo"

Novosteo - Crunchbase Company Profile & Funding

Novosteo, Inc. is a startup developing and delivering new drugs for the treatment of bone injury and diseases that impact patients' morbidity, mortality and loss of mobility and productivity …See details»

Cortexyme acquires Novosteo, rebrands with new …

May 10, 2022 · Despite past troubles tied to its lead drug, Cortexyme is forging ahead with new leadership, the acquisition of skeletal-focused biotech Novosteo and even a name change on the horizon.See details»

Cortexyme Announces Agreement to Acquire Novosteo

The acquisition of Novosteo expands Cortexyme’s drug development pipeline into rare disease indications with the addition of NOV004, a bone targeting molecule designed to accelerate …See details»

Bone treatment startup raises $5.5 M in Series A …

Feb 4, 2021 · Novosteo Inc. is a startup developing and delivering new drugs for the treatment of bone injury and diseases that impact patients’ morbidity, mortality and loss of mobility and productivity associated with bone fractures, bone …See details»

Cortexyme Successfully Completes Acquisition of Novosteo

In conjunction with the close of the Novosteo acquisition, Cortexyme reported that the Compensation Committee of the company’s Board of Directors approved grants of stock …See details»

Cortexyme Successfully Completes Acquisition of …

May 20, 2022 · SOUTH SAN FRANCISCO, Calif.-- ( BUSINESS WIRE )--Cortexyme, Inc. (Nasdaq: CRTX), a clinical-stage biopharmaceutical company developing therapeutic approaches to improve the lives of patients...See details»

Quince Therapeutics acquires Novosteo - 2022-05-10 - Crunchbase

May 10, 2022 · Novosteo Novosteo, test the efficacy of a new drug to help reduce complications from a broken bone due to a fall. Acquiring Organization: Quince Therapeutics Cortexyme is …See details»

Cortexyme Successfully Completes Acquisition of Novosteo

May 20, 2022 · Cortexyme, Inc., a clinical-stage biopharmaceutical company developing therapeutic approaches to improve the lives of patients diagnosed with degenerative diseases, …See details»

Cortexyme to Acquire Novosteo, Expanding Pipeline …

May 10, 2022 · The acquisition of Novosteo expands Cortexyme’s drug development pipeline into rare disease indications with the addition of NOV004, a bone targeting molecule designed to accelerate fracture repair, including in …See details»

Injectable pharmaceutical aims to accelerate bone healing, …

Feb 26, 2019 · Orthopaedic Research Society presents first-place award to Novosteo for its work in developing an injectable drug to heal broken bones faster. WEST LAFAYETTE, Ind. – Every …See details»

Novosteo sees growth as it develops injectable drug to …

Sep 23, 2020 · Novosteo Inc. father and son co-founders Philip Low and Stewart Low have been developing and commercializing a targeted drug combination that, when injected, is shown to expedite bone fracture healing. (Purdue Research …See details»

Research Bridge Partners' Portfolio Company, Novosteo, Inc., …

Mar 16, 2021 · Novosteo, Inc. is a startup developing and delivering new drugs for the treatment of bone injury and diseases that impact patients' morbidity, mortality and loss of mobility and …See details»

Bone treatment startup raises $5.5 M in Series A financing

Feb 4, 2021 · Novosteo Inc. is a startup developing and delivering new drugs for the treatment of bone injury and diseases that impact patients’ morbidity, mortality and loss of mobility and …See details»

Bone treatment startup raises $5.5 M in Serie - EurekAlert!

Feb 4, 2021 · Novosteo Inc., a preclinical-stage biotechnology startup focused on the development of bone-targeted therapeutics, announced Thursday (February 4) the closing of a …See details»

Injectable drug aims to accelerate bone healing - Medical Xpress

Feb 26, 2019 · Novosteo, a Purdue-affiliated startup, is advancing a technology shown to repair bone fractures faster and at greater benefit to a patient.See details»

Research Bridge Partners Makes Seed Capital Investment In …

AUSTIN, Texas, Aug. 8, 2019 — Research Bridge Partners—a 501 (c) (3) organization that makes formative investments in biomedical startup companies based on the breakthroughs of …See details»

Injectable drug for faster healing of bone fractures prepares for ...

Feb 11, 2020 · Novosteo, a Purdue-affiliated startup, is advancing a technology shown to repair bone fractures faster and at greater benefit to a patient. The image above shows fractured …See details»

Cortexyme Announces Agreement to Acquire Novosteo

May 10, 2022 · The acquisition of Novosteo expands Cortexyme’s drug development pipeline into rare disease indications with the addition of NOV004, a bone targeting molecule designed to …See details»

Research Bridge Partners’ Portfolio Company, Novosteo, Inc., …

Mar 16, 2021 · Novosteo, Inc. is a startup developing and delivering new drugs for the treatment of bone injury and diseases that impact patients’ morbidity, mortality and loss of mobility and …See details»

Injectable drug for faster healing of bone fr | EurekAlert!

Feb 11, 2020 · image: Novosteo, a Purdue University-affiliated startup, is advancing a technology shown to repair bone fractures faster and at greater benefit to a patient. The image above …See details»

linkstock.net © 2022. All rights reserved